These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3313895)

  • 1. Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment: a cause of chronic liver disease after kidney transplantation.
    Gerlag PG; van Hooff JP
    Transplant Proc; 1987 Oct; 19(5):3699-703. PubMed ID: 3313895
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic sinusoidal dilatation with portal hypertension during azathioprine treatment after kidney transplantation.
    Gerlag PG; Lobatto S; Driessen WM; Deckers PF; Van Hooff JP; Schröder E; Assmann KM; Van Haelst UJ
    J Hepatol; 1985; 1(4):339-48. PubMed ID: 3902952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic vascular disease after kidney transplantation: report of two cases and review of the literature.
    Adler M; Delhaye M; Deprez C; Hardy N; Gelin M; De Pauw L; Vereerstraeten P; Cremer M; Toussaint C
    Nephrol Dial Transplant; 1987; 2(3):183-8. PubMed ID: 3114679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine.
    Marubbio AT; Danielson B
    Gastroenterology; 1975 Sep; 69(3):739-43. PubMed ID: 1098955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nodular regenerative hyperplasia of the liver associated with azathioprine therapy].
    Duvoux C; Kracht M; Lang P; Vernant JP; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1991; 15(12):968-73. PubMed ID: 1783253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of idiopathic portal hypertension after renal transplantation.
    Yanagisawa N; Sugaya H; Yunomura K; Harada T; Hisauchi T
    Gastroenterol Jpn; 1990 Oct; 25(5):643-8. PubMed ID: 2227256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation.
    Elariny HA; Mizrahi SS; Hayes DH; Boudreaux JP; Hussey JL; Farr GH
    Transpl Int; 1994 Jul; 7(4):309-13. PubMed ID: 7916934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible liver damage after azathioprine.
    Zarday Z; Veith FJ; Gliedman ML; Soberman R
    JAMA; 1972 Nov; 222(6):690-1. PubMed ID: 4562099
    [No Abstract]   [Full Text] [Related]  

  • 9. Azathioprine and hepatic venocclusive disease in renal transplant patients.
    Katzka DA; Saul SH; Jorkasky D; Sigal H; Reynolds JC; Soloway RD
    Gastroenterology; 1986 Feb; 90(2):446-54. PubMed ID: 3510146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical case of the month. Hepatoportal sclerosis in a patient treated with azathioprine].
    Roland S; Delwaide J; Cornet G; Mahieu P; Jacquet N; Belaiche J
    Rev Med Liege; 1998 Aug; 53(8):450-3. PubMed ID: 9810203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations.
    Haboubi NY; Ali HH; Whitwell HL; Ackrill P
    Am J Gastroenterol; 1988 Mar; 83(3):256-61. PubMed ID: 3278593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver parenchyma lesions and portal hypertension in granulomatous hepatitis].
    Liehr H; Grün M; Leinweber B; Kühn HA
    Acta Hepatosplenol; 1971; 18(4):320-8. PubMed ID: 4329265
    [No Abstract]   [Full Text] [Related]  

  • 13. Idiopathic portal hypertension in a renal transplant patient after long-term azathioprine therapy.
    Lorenz R; Brauer M; Classen M; Tornieporth N; Becker K
    Clin Investig; 1992 Feb; 70(2):152-5. PubMed ID: 1600341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favourable outcome of hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine, treated by portacaval shunt. Report of a case and review of the literature.
    Eisenhauer T; Hartmann H; Rumpf KW; Helmchen U; Scheler F; Creutzfeldt W
    Digestion; 1984; 30(3):185-90. PubMed ID: 6389237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver disease in kidney transplant patients receiving azathioprine.
    Ireland P; Rashid A; von Lichtenberg F; Cavallo T; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):29-37. PubMed ID: 4577390
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic venous pressure gradient and transjugular liver biopsy to assess patients with kidney failure and chronic liver disease.
    García Agudo R; Aoufi Rabih S; Pérez Roldán F; Guzmán Ames F; González Carro P; Ruiz Carrillo F; Cuesta Domínguez R
    Nefrologia; 2011; 31(4):490-2. PubMed ID: 21738254
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation.
    Nataf C; Feldmann G; Lebrec D; Degott C; Descamps JM; Rueff B; Benhamou JP
    Gut; 1979 Jun; 20(6):531-7. PubMed ID: 381128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic dysfunction in recipients of renal allografts.
    Berne TV; Chatterjee SN; Craig JR; Payne JE
    Surg Gynecol Obstet; 1975 Aug; 141(2):171-5. PubMed ID: 168654
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic sarcoidosis with portal hypertension].
    Tîrcoveanu E; Strat V; Bălan G; Dobrescu G; Florea N; Roşca V; Zugun F
    Rev Ig Med Muncii Med Soc Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1990; 39(1):73-5. PubMed ID: 2223727
    [No Abstract]   [Full Text] [Related]  

  • 20. [Toxic lesion of the liver in patients with kidney allograft].
    Kuchinskiĭ IN; Armagomedov AA; Demidov AT
    Urol Nefrol (Mosk); 1978; (3):21-5. PubMed ID: 351909
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.